chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vertigo; dizziness; blurred vision; This is a follow up spontaneous report from a contactable consumer (Patient). A 31-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 05Feb2021 (Batch/Lot Number: EM9810) as single dose for covid-19 immunisation. Medical history included none. No concomitant drugs were reported. On 05Feb2021 16:35, The patient experienced vertigo, dizziness and blurred vision on unspecified time. Consumer says she just had her first dose of the Pfizer COVID-19 vaccine around 03:00-03:15PM today, and then about 20 minutes ago she had vertigo, or a dizzy spell then bad blurred vision. She says she feels normal or feels ok now, but it took like 5 minutes to get better, maybe 10-15 minutes. Consumer says she would like to know if this is normal, or if she should seek medical attention. she has had no recent vaccinations and is on two meds but they are not new, she has taken them 6 months already. The action taken in response to the events for BNT162B2 was not applicable. The outcome of event was recovered.
All ten toes turned purple within 4 days after 2nd Moderna Vaccination.  From base of MTP joint distally
After I had the shot, my arm hurt all day long.  I had the shot 8/4.  8/5 and 6 I was barely able to raise the arm.  Today is 8/7 and my arm is still painful.  I can raise it a little better.
Very dizzy/Vertigo; Very dizzy/Vertigo; Nausea; diarrhea; This is a spontaneous report from a contactable other hcp.    A 50-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 13Aug2021 14:30 as dose 1, single for covid-19 immunisation.Medical history included rheumatoid arthritis, food allergy. known allergies: dairy, strawberries, latex, penicillin, hypersensitivity.The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was reported that, on 14Aug2021 03:00, the patient experienced very dizzy/vertigo and Diarrhoea with outcome of not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
started to dry heave like he wanted to throw up but it never happened.; This spontaneous case was reported by a consumer and describes the occurrence of RETCHING (started to dry heave like he wanted to throw up but it never happened.) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058H21A, 030M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Nov-2021, the patient experienced RETCHING (started to dry heave like he wanted to throw up but it never happened.). At the time of the report, RETCHING (started to dry heave like he wanted to throw up but it never happened.) outcome was unknown.            Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to MOD-2021-400094 (Patient Link).
This spontaneous report as received from a healthcare worker refers to multiple unspecified patients of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On an unknown date, the patients were vaccinated with improperly stored VARIVAX (lot#, expiry date, dosing details, anatomical location, route were unknown) for prophylaxis. Previous temperature excursion was reported. Data logger was involved. No adverse effects were reported. There were no product quality complaints (PQC) involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA009095.
Received Pfizer vaccine 5 days after Moderna vaccine; Received Pfizer vaccine 5 days after Moderna vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer vaccine 5 days after Moderna vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received Pfizer vaccine 5 days after Moderna vaccine) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer vaccine 5 days after Moderna vaccine). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received Pfizer vaccine 5 days after Moderna vaccine). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Received Pfizer vaccine 5 days after Moderna vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received Pfizer vaccine 5 days after Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment medications were provided
Period after COVID vaccine was very light and then passed large blot clot.  This has never happened before and I have regular periods.
I have been in more pain. Lump on arm of injection site, warm to the touch. Temp of 99. More tired then usual.
arm is red; arm is swollen; the pain in arm; headache; aches/pain; chills; This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th November 2022, the patient received the 1st dose of Shingrix. In November 2022, less than a week after receiving Shingrix, the patient experienced erythema of extremities, swelling arm, pain in arm, headache, pain and chills. On an unknown date, the outcome of the erythema of extremities, swelling arm and pain in arm were not recovered/not resolved and the outcome of the headache, pain and chills were recovered/resolved.   It was unknown if the reporter considered the erythema of extremities, swelling arm, pain in arm, headache, pain and chills to be related to Shingrix.     Additional Information: GSK Receipt Date: 15-NOV-2022 Reporter's Comments:  The patient received her dose of Shingrix and had experienced chills, aches, headaches, pain, and her arm was red and swollen.  The reporter consented to follow up.
Heart palpitations and rash 9 days after vaccination on the left arm at injection site. Rash was raised, red, itchy, and slight pain.
This spontaneous report was received from a healthcare worker (medical assistant) and refers to multiple unspecified patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions and concomitant therapies was provided. On an unknown dates, the patients were vaccinated with improperly stored doses of M-M-R II (lot # K002816, expiration date 26-FEB-2016, exact doses and route of administration were not reported). No adverse effects were reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same reporter. Follow-up information has been received from a nurse on 20-OCT-2015. On 27-AUG-2015, a patient of unknown age and gender received a dose of M-M-R II (lot # K002816, expiration date 26-FEB-2016), which was exposed to a maximum temperature 49F for a total of 11 days prior to administration. All telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports received from the same source. Additional information has been requested. Reporter , patient, suspect therapy, event and the narrative have been updated.
started diarrhea 2 days p/shots, low grade fever, vomiting projectile, lasting 4 days;
Full body hives with extreme itch. Lips puffy.} Rapid onset. No respiratory difficulty.
erythematous rash, hot, indurated at site of vaccine, some itching painful to touch, was instructed to apply ice, Motrin and plan to start clindamycin for cellulitis if no improvement was given lst dose of varicella vaccine on 9/12/2018, develop similar reaction was placed on clindamycin for concerns for cellulitis a that time
Information has been received from a nurse concerning a 31 year old male with anaemia macrocytic, a history of immune thrombocytopenic purpura and no known drug allergies who on 08-JUN-2009 was vaccinated with the first 0.5 ml dose of PNEUMOVAX. On 09-JUN-2009 the patient's right arm was sore, swollen, and salmon color. The patient also had a maculopapular rash on his right arm, headache, high fever of 102 to 103F, body aches and nausea. The patient's right arm hurts to move. The symptoms were considered to be disabling because "patient has to stay in bed". Medical attention was sought via office visit and the patient was treated with ROCEPHIN 2 grams. Laboratory studies were performed on 10-JUN-2009. The patient's complete blood count was abnormally high with left shift. The patient's white blood cell count was 1900, bilirubin was elevated, platelets were 88,000 (units and normal ranges not provided); chest x-ray, influenza, blood culture and urinalysis were negative. At the time of report, the patient was recovering. This is one of several reports from the same source. A lot check is being initiated. Additional information has been requested.
Patient received the vaccine even though he was under age (16 years old at the time of vaccination). No adverse event with the patient. Reporting due to age limitations.
Pt recv vax on 3/5/99; on 3/6/99 pt exp not seeing well (unable to focus); tx=glasses for distance vision-bifocals
pt recv vax & the day following vax exp soreness @ inj site, malaise & h/a;sx resolved w/in 48hr;the reporter felt that the adverse events occurred as a result of the overdosage;
10 days after  first vaccine had large urticarial lesion on back; resolved on its own. 10 days after 2nd vaccine developed palpable purpura on both anterior shins. Non-resolving after one month. Labs done today and results pending.
patient can no longer walk with a walker (wheelchair only now); physical downturn; hard to stand; has been weaker since; cognitive downturn; This spontaneous case was reported by a consumer and describes the occurrence of WALKING DISABILITY (patient can no longer walk with a walker (wheelchair only now)), PHYSICAL DISABILITY (physical downturn), DYSSTASIA (hard to stand), ASTHENIA (has been weaker since) and COGNITIVE DISORDER (cognitive downturn) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Alzheimer's disease since 2014.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced PHYSICAL DISABILITY (physical downturn), DYSSTASIA (hard to stand), ASTHENIA (has been weaker since) and COGNITIVE DISORDER (cognitive downturn). On 04-Feb-2021, the patient experienced WALKING DISABILITY (patient can no longer walk with a walker (wheelchair only now)). At the time of the report, WALKING DISABILITY (patient can no longer walk with a walker (wheelchair only now)), PHYSICAL DISABILITY (physical downturn), DYSSTASIA (hard to stand), ASTHENIA (has been weaker since) and COGNITIVE DISORDER (cognitive downturn) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: Follow-up received no new information was reported.
patient almost had a heart attack from Pfizer, and almost died; This is a spontaneous report received from contactable reporter(s) (Physician). Other Case identifier(s): 2023NVX-US-000001337 (Novavax).  A male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDIAL INFARCTION (medically significant, life threatening), outcome "unknown", described as "patient almost had a heart attack from Pfizer, and almost died". Clinical course: On 19Oct2023, it was reported that a patient started treatment on an unreported date with Pfizer BioNTech COVID-19 vaccine unspecified dose for COVID-19 vaccination. It was reported the patient almost had a heart attack from Pfizer, and almost died.   The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information available, the causal relationship between the reported event and suspect drug bnt162b2 omi xbb.1.5 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
This spontaneous report as received from a nurse refers to 2 patients of unknown age and gender. On 03-JUN-2015 the two patients missed prescribed doses of unspecified frozen vaccine which may have been ZOSTAVAX (lot number and expiry date unknown) (dosing regimen and frequency unknown) for an unknown indication due to improper storage. No concomitant medications were reported. No adverse events were reported. The action taken with the therapy with vaccine ZOSTAVAX was unknown. The outcome of the events was unknown. The relatedness of the events to the therapy with vaccine ZOSTAVAX was unknown. No product quality issue was reported. This is one of the many reports received from the same source. Additional information has been requested.
Developed hoarseness in evening 10/16 next day. No other symptom. Improved on 10/16.
Left arm soreness: 3/2/2022 only (minor event) Muscular Weakness, lack of energy starting 3/4/2022 thru present 3/6/2022: Feeling nauseous, light headed; ; loss of appetite (had high BP meds at 9am), Feeling dizzy at 10am went from standing to sitting then became unconscious and fell to the floor.  A doctor at the scene revived me after 10 minutes. Dr could not get a pulse initially. EMT's took me to hospital where I got IV and anti nausea meds and 2 stitches for laceration on top of head. Walked successfully on my own. Released at 3pm. thru 3/8/2022: I feel occasional light headness and lack of energy. (I'm 90% recovered)
Exactly one week later a severe rash with raised hives presented on both arms and around waist. I sought treatment at a local urgent care, was treated with steroid shots and benadryl and released. Symptoms resolved within 1-2 hours.  HOWEVER... I did receive the 2nd dose at Pharmacy on 4/12/2021.  It was Moderna, lot #036AZ1A (or 21A - hard to read writing), also intramuscular injection in right arm. There were no sudden or obvious reactions after the 2nd injection.  HOWEVER... In the months since then, I have had recurring skin rashes like never before in my life.  I have photos of rashes on my arm and chest on 1/18/22 and 1/19/22 for which I saw a dermatologist on 1/19/22.  Their diagnosis was eczema with topical lotions, etc as the prescribed treatment. There was also a widespread rash on my back which presents as tiny red bumps with intense itching.  This rash has not subsided for nine months.  I have never received another booster shot and actually had Covid-19 in July 2022. Perhaps tis has intensified my reactions, as just 2 days ago on 9/23/22, a large rash has now developed on my left thigh.  I have photos of my back from 9/23/22 and thigh from 9/25/22.  The itching is intense and has not subsided.  I have never had these rashes in my life before receiving the Moderna shot.  At least, not in a sustained manner, such as currently presenting on my back and thigh.  This makes me draw a connection to the Moderna shot.  I have read online of studies that identify these same, specific skin rashes as a result of HAVING Covid-19.  They identify them as urticaria and erythemato-papular rash.  I also have an acquaintance with the same red bumpy rash all over her body.  She is a female, around 90 years old.  Her medical provider identified it as Grover's Disease (transient acantholytic dermatosis).  She too wonders if it is related to the Covid-19 shots.  (I do not know which she had.)
pt recvd vax; pt devel hives & pain both elbows; had a few hives daily;
This spontaneous report was received from a health care professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with PROQUAD (Merck) (L016394; expiry: 08-NOV-2016) (dose, route and frequency unspecified). Other suspect therapies included VARIVAX (Merck) (dose, route, frequency and lot # unspecified). Concomitant medications and medical history were not reported. Nurse reported that on an unknown date VARIVAX (Merck) and PROQUAD (Merck) were inadvertently administered to a patient during the same office visit (overdose). No adverse effects reported. No additional information to report. Additional information has been requested.
Spiked fever evening of injections, was in bed the next day with fever & Lt arm pain. Two days later Lt arm swollen, redness of upper arm.
Within the second day after receiving the vaccine : Intermittent drastic rise in blood pressure in conjunction with heart palpatations. Nausea. Drastic Increase in thirst. Intermittent bouts of restlessness. Inability to perform physical exercises without cardiac complications.  Burping and excessive gas. Symptoms persist.
pain that arm from the injection site down to her hand; whole arm is hurting all the way to the hand and arm started aching; This is a spontaneous report received from a contactable consumer (patient). A 59-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: ER2739), via an unspecified route of administration on left arm on 05Apr2021 (at the age of 59-years-old) as single dose for COVID-19 immunisation. Medical history included ongoing asthma (Diagnosed in November or December of 2020 while she had the COVID virus; went for a lung test in January 2021). Concomitant medications were not reported. Patient reports that she did have a hard time when she got COVID virus in 2020. Patient reports she had a lot of breathing problems when she had the COVID virus and she went to a lung specialist and was diagnosed with asthma. Patient reported that she received the COVID vaccine at 5:30 or 6:00 pm on 5Apr2021 and then her arm started aching. She states that to treat the pain, she is putting ice on it and everything but that the pain is not going away. She reports that the pain began around 8:30 or 9pm on 05Apr2021. She reports that she had to take her rings off of her hand because it is hurting so much. Patient reports the pain is staying the same except it gets better when ice is on it and that she is taking ibuprofen to help with the pain as well. Patient states that if she doesn't do ice and ibuprofen the pain is at a 10. Additional Vaccines Administered on Same Date of the Pfizer Suspect Additional Administered Vaccines were none. No other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient was not recovered from the events.  No follow-up attempts are needed. No further information is expected.
Swelling and redness in Right arm. Saw Doctor on 9/14 and was told to take Benadryl and ibuprofen.  Saw Doctor on 9/15 was told she had cellulitis and was given oral antibiotics and a injection of antibiotics. She had a temperature.
report completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose01/07/21 2nd dose01/28/21 Diagnosed covid positive:08/28/21 Symptom onset:08/27/21 Exposure: Symptoms:cough, fatigue,chills, runny nose, haedache
Flu like symptoms; Dizziness; Joint Pain; Headache; Nausea; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9269), via an unspecified route of administration in left arm on 09Feb2021 at 13:30 at single dose for COVID-19 immunisation. The patient was allergic to codeine. Concomitant medications were not reported. No covid prior vaccination. No covid tested done post vaccination. The patient was not pregnant at the time of vaccination. On 09Feb2021 at 07:00 PM, the patient experienced flu like symptoms, dizziness, Joint pain, headache and nausea. No treatment was received. The outcome of the events was recovered.
Patient had swelling on the arm from injection site to just above the elbow.  It is also hot and painful.  She stated she was able to move it (raise the arm) on Saturday which she wasn't able to do Friday evening. She spoke with her doctor on Sunday and he said to continue with benadryl and tylenol. She still has swelling and redness around elbow but it is not as hot or as painful as before.
pt recvd vax;devel local rxn characterized by redness, induration & pain & warmth; tx w/ Ancef 2 g followed by dicloxacillin for 7 days;
Initial misuse report received from a healthcare professional on 06 January 2014. This is an invalid case as individual patient identifiers are missing. It was reported some patient had received ACTHIB vaccine that was reconstituted with sterile water. No information was provided regarding the patients. No adverse event was reported. Documents held by sender: none.
Narrative:  Pt had both covid-19 vaccines on 4/16/21 & 5/14/21. Per CPRS noted pt died on 5/26/2021. No information available on nature of pt's death happened outpatient. Pt did not have comorbid diagnosis. Pt did have diagnosis of depression since 2019 & was a transgender (female at birth) & hx of hand surgery. Not clear if death related to covid vaccine or not.
Patient received Tdap on Lt. deltoid. Pt. came back on 07/05/17 and said that he felt very cold, little bit dizzy, tired, and Lt. deltoid swollen, body temperature was 98 F. He felt little dizzy and Lt. armpit swollen today. Dr. saw pt. in the clinic without new order made.